Insider Transactions in Q3 2021 at Clovis Oncology, Inc. (CLVS)
Insider Transaction List (Q3 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 02
2021
|
Lindsey Rolfe Officer |
SELL
Open market or private sale
|
Direct |
347
-0.44%
|
$1,388
$4.89 P/Share
|
|
Sep 02
2021
|
Paul Edward Gross Officer |
SELL
Open market or private sale
|
Direct |
249
-0.45%
|
$996
$4.89 P/Share
|
|
Sep 02
2021
|
Gillian C Ivers Read Officer |
SELL
Open market or private sale
|
Direct |
304
-0.12%
|
$1,216
$4.89 P/Share
|
|
Sep 02
2021
|
Daniel W Muehl Officer |
SELL
Open market or private sale
|
Direct |
249
-0.4%
|
$996
$4.89 P/Share
|
|
Sep 02
2021
|
Thomas C. Harding Officer |
SELL
Open market or private sale
|
Indirect |
7
-0.5%
|
$28
$4.89 P/Share
|
|
Sep 02
2021
|
Thomas C. Harding Officer |
SELL
Open market or private sale
|
Direct |
141
-3.81%
|
$564
$4.89 P/Share
|
|
Sep 01
2021
|
Lindsey Rolfe Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
688
+0.87%
|
-
|
|
Sep 01
2021
|
Paul Edward Gross Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
563
+1.0%
|
-
|
|
Sep 01
2021
|
Gillian C Ivers Read Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
688
+0.27%
|
-
|
|
Sep 01
2021
|
Daniel W Muehl Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
563
+0.91%
|
-
|
|
Sep 01
2021
|
Thomas C. Harding Officer |
BUY
Exercise of conversion of derivative security
|
Indirect |
19
+1.33%
|
-
|
|
Sep 01
2021
|
Thomas C. Harding Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
281
+7.05%
|
-
|
|
Aug 03
2021
|
Paul Edward Gross Officer |
SELL
Open market or private sale
|
Direct |
4,507
-4.04%
|
$18,028
$4.82 P/Share
|
|
Aug 03
2021
|
Lindsey Rolfe Officer |
SELL
Open market or private sale
|
Direct |
4,195
-2.66%
|
$16,780
$4.82 P/Share
|
|
Aug 03
2021
|
Daniel W Muehl Officer |
SELL
Open market or private sale
|
Direct |
4,507
-3.64%
|
$18,028
$4.82 P/Share
|
|
Aug 03
2021
|
Thomas C. Harding Officer |
SELL
Open market or private sale
|
Indirect |
62
-4.27%
|
$248
$4.82 P/Share
|
|
Aug 03
2021
|
Thomas C. Harding Officer |
SELL
Open market or private sale
|
Direct |
1,678
-22.23%
|
$6,712
$4.82 P/Share
|
|
Aug 03
2021
|
Gillian C Ivers Read Officer |
SELL
Open market or private sale
|
Direct |
3,683
-0.72%
|
$14,732
$4.82 P/Share
|
|
Aug 01
2021
|
Paul Edward Gross Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,249
+8.4%
|
-
|
|
Aug 01
2021
|
Lindsey Rolfe Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
8,374
+5.04%
|
-
|
|
Aug 01
2021
|
Daniel W Muehl Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,249
+7.64%
|
-
|
|
Aug 01
2021
|
Thomas C. Harding Officer |
BUY
Exercise of conversion of derivative security
|
Indirect |
181
+11.08%
|
-
|
|
Aug 01
2021
|
Thomas C. Harding Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,376
+30.88%
|
-
|
|
Aug 01
2021
|
Gillian C Ivers Read Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
8,374
+1.61%
|
-
|
|
Jul 01
2021
|
Thomas C. Harding Officer |
SELL
Open market or private sale
|
Indirect |
26
-2.0%
|
$130
$5.79 P/Share
|
|
Jul 01
2021
|
Thomas C. Harding Officer |
BUY
Exercise of conversion of derivative security
|
Indirect |
63
+4.63%
|
-
|